Diabetes and gene therapy: from lab bench to bedside

Professor Ann Simpson, UTS School of Life Sciences and Centre for Health Technologies, is a leading Australian diabetes researcher who has developed an artificial insulin producing cell to treat Type 1 diabetes, an autoimmune disease that destroys the insulin-producing cells in the pancreas. Together with industry partner Pharmocyte Biotech Ann’s research aims to develop translational  biotherapies that can be tailored to individual patients at the bedside.

• #education
• #uts
• #science
• #uts_science
• #professor_ann_simpson
• #diabetes
• #type_1_diabetes
• #uts_research
• #melanin_cells
• #autoimmune_disease
• #translational_biotherapeutics
• #australia
• #research
• #pharmocyte_biotech
• #centre_for_health_technologies
• #cell_therapy